In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our
privacy policy.



Success story | Portfolio consolidation and governance in the pharmaceutical industry



Save this article


Laurence Massat

Partner / France


Portfolio consolidation and governance in the pharmaceutical industry



Our client, a pharmaceutical company, faced difficulties to reach its objectives of new product launch and product changes delivery. These difficulties were partly due to the lack of portfolio management, in a context of high volume of projects and limited resources.

CYLAD was mandated to :

  • Consolidate, characterize and rationalize the portfolio of all ongoing and future projects
  • Develop an optimized portfolio management system



For the portfolio consolidation, CYLAD :

  • structured the portfolio architecture based on project triggers and types
  • defined the attributes necessary to facilitate selection and prioritization (e.g. value, risk)
  • consolidated all ongoing or forecasted projects within the organization, in a robust shared baseline


Simultaneously, CYLAD defined the portfolio management system:

  • Definition and sizing of the organization around newly created Portfolio Manager position, with clear roles and responsibilities
  • Demand management & steering processes, methods, routines and rules for portfolio governance, including project in-flow, monitoring, workload/capacity management and arbitration.



  • Optimized consolidated portfolio baseline
  • Evaluation matrix
  • Portfolio management handbook



  • SHARED SINGLE SOURCE OF TRUTH : Exhaustive project list/portfolio baseline
  • PRIORIZATION RULES FOR RESOURCE ALLOCATION of portfolio pipeline based on value/effort analysis
  • TEAMS ENGAGED thanks to clear organization and management system


Download PDF